TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT06603818

Immunotherapies in Combination With Stereotactic Body Radiation Radiotherapy in Microsatellite Stable (MSS) Metastatic Colorectal Cancer (mCRC)

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“The trial is closing due to findings from a related study, prompting the sponsor to discontinue development and end this study.”

The sponsor’s own words in the registry.

Life of this trial

2024202520262027Registered2024-09-17Planned start2025-08-15 (planned)Withdrawn (as of)2026-02-19

Vital statistics

Status
Withdrawn
Phase
Phase 2
Sponsor
National Cancer Institute (NCI)
Sponsor type
US National Institutes of Health
Conditions
Microsatellite Stable Metastatic Colorectal Cancer; Metastatic Colorectal Cancer; Colorectal Cancer
Interventions
Tiragolumab; Atezolizumab; Stereotactic Body Radiation Therapy (SBRT)
Participants
0
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.